TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.
We Recommend
Disclosures
<p>Nothing to disclose</p>
New at TCTMD? Register today!
Enter the email you used to register to reset your password.